Emerging Infections
- 1st Edition, Volume 1 - June 28, 2011
- Latest edition
- Editors: Richard M. Krause, John I. Gallin, Anthony S. Fauci
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 3 8 8 6 6 3 - 7
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 5 3 0 8 5 - 7
Emerging Infections is the first volume of the new Biomedical Research Reports Series, which will provide annual updates on hot topics of interest to a broad spectrum of the biomed… Read more
Emerging Infections is the first volume of the new Biomedical Research Reports Series, which will provide annual updates on hot topics of interest to a broad spectrum of the biomedical research community. This book provides state-of-the-art reviews of new and reemerging bacterial, viral, and parasitic infections, their life cycles, host defense evasion strategies, and clinical features. It includes the history of infectious disease outbreaks, population and evolutionary biology of human pathogens, and current epidemiological models that describe how ecological and demographic changes produce new epidemics.
- Provides reviews on hot topics of interest to the biomedical research community
- Editor and contributors are renowned international experts
- Covers the major established pathogens as well as the new and sensational--such as mad cow disease, hantavirus pulmonary syndrome, pathogenic E. Coli, and flesh-eating bacteria
AUDIENCE: Basic and clinical researchers in microbiology, immunology, infectious disease, and public health.
R.M. Krause, Introduction to Emerging Infectious Diseases: Stemming the Tide.
R.M. Anderson, Analytical Theory of Epidemics.
J.D. McKinney, W.R. Jacobs, Jr., and B.R. Bloom, Persisting Problems in Tuberculosis.
E.J. Rubin, M.K. Waldor, and J. Mekalanos, Mobile Genetic Elements and the Evolution of New Epidemic Strains of Vibrio cholerae.
T.S. Whittam, E.A. Mcgraw, and S.D. Reid, Pathogenic Escherichia coli 0157:H7: A Model for Emerging Infectious Diseases.
J.M. Musser and R.M. Krause, The Revival of Group A Streptococcal Diseases, With a Commentary on Staphylococcal Toxic Shock Syndrome.
A.C. Steere, Lyme Disease.
J.E. Davies and V. Webb, Antibiotic Resistance in Bacteria.
R.G. Webster, Influenza: An Emerging Microbial Pathogen.
E.C. Holmes, L.M. Bartley, and G.P. Garnett, The Emergence of Dengue: Past, Present, and Future.
T.C. Quinn and A.S. Fauci, The AIDS Epidemic: Demographic Aspects, Population Biology, and Virus Evolution.
N. Nathanson and S.T. Nichol, Korean Hemorrhagic Fever and Hantavirus Pulmonary Syndrome: Two Examples of Emerging Hantaviral Disease.
F.A. Murphy and C.J. Peters, Ebola Virus: Where Does it Come from and Where is it Going?
W.J. Tabachnik, Arthropod-borne Pathogens: Issues for Understanding Emerging Infectious Diseases.
A.A.F. Mahmoud, "New" Intestinal Parasitic Protozoa.
J. Hope, Transmissible Spongiform Encephalopathies of Man and Animals.
K.P. Day, Malaria: A Global Threat.
Subject Index.
R.M. Anderson, Analytical Theory of Epidemics.
J.D. McKinney, W.R. Jacobs, Jr., and B.R. Bloom, Persisting Problems in Tuberculosis.
E.J. Rubin, M.K. Waldor, and J. Mekalanos, Mobile Genetic Elements and the Evolution of New Epidemic Strains of Vibrio cholerae.
T.S. Whittam, E.A. Mcgraw, and S.D. Reid, Pathogenic Escherichia coli 0157:H7: A Model for Emerging Infectious Diseases.
J.M. Musser and R.M. Krause, The Revival of Group A Streptococcal Diseases, With a Commentary on Staphylococcal Toxic Shock Syndrome.
A.C. Steere, Lyme Disease.
J.E. Davies and V. Webb, Antibiotic Resistance in Bacteria.
R.G. Webster, Influenza: An Emerging Microbial Pathogen.
E.C. Holmes, L.M. Bartley, and G.P. Garnett, The Emergence of Dengue: Past, Present, and Future.
T.C. Quinn and A.S. Fauci, The AIDS Epidemic: Demographic Aspects, Population Biology, and Virus Evolution.
N. Nathanson and S.T. Nichol, Korean Hemorrhagic Fever and Hantavirus Pulmonary Syndrome: Two Examples of Emerging Hantaviral Disease.
F.A. Murphy and C.J. Peters, Ebola Virus: Where Does it Come from and Where is it Going?
W.J. Tabachnik, Arthropod-borne Pathogens: Issues for Understanding Emerging Infectious Diseases.
A.A.F. Mahmoud, "New" Intestinal Parasitic Protozoa.
J. Hope, Transmissible Spongiform Encephalopathies of Man and Animals.
K.P. Day, Malaria: A Global Threat.
Subject Index.
- Edition: 1
- Latest edition
- Volume: 1
- Published: June 28, 2011
- Language: English
RK
Richard M. Krause
Affiliations and expertise
National Institutes of Health, Bethseda, Maryland, U.S.A.JG
John I. Gallin
Dr. John Gallin was appointed to the dual roles of National Institutes of Health (NIH) Associate Director for Clinical Research and inaugural Chief Scientific Officer, the Clinical Center in August 2016. He served as the Director NIH Clinical Center from 1994-2017 after serving 9 years as Scientific Director of the National Institute of Allergy and Infectious Diseases (NIAID) and 12 years as Chief of the Laboratory of Host Defenses. During his tenure as Director of the NIH Clinical Center, Dr. Gallin helped to lead the design, construction, and activation of the Mark O. Hatfield Clinical Research Center, the largest hospital in the world totally dedicated to clinical research. He also oversaw the establishment of a new curriculum for clinical research training, now offered globally reaching over 25,000 students annually in 168 countries, and the development of new information systems for biomedical, translational and clinical research. In 2011, Dr. Gallin accepted, on behalf of the NIH Clinical Center, the Lasker–Bloomberg Public Service Award for its rich history of medical discovery through clinical research. His primary research interests are rare immune disorders of phagocytes, with a focus on chronic granulomatous disease (CGD). His laboratory described the genetic basis for several forms of CGD and other disorders of phagocytes and has done pioneering research that has reduced life-threatening bacterial and fungal infections in patients with these disorders. He has published more than 380 articles in scientific journals and edited two textbooks – Inflammation, Basic Principles and Clinical Correlates (Lippincott, Williams, and Wilkins, 1999, 3rd edition) and Principles and Practice of Clinical Research (Academic Press, 4th edition 2018). He has received numerous awards and honors for his accomplishments and in 2022 received the Weill Cornell Medical College Alumni Award of Distinction, the medical college’s most prestigious alumni award. Dr. Gallin is a member of the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine of the National Academy of Sciences, a Master of the American College of Physicians, and a Fellow of the Royal College of Physicians-London. He retired from his administrative positions in 2023 and is now an Adjunct Senior Investigator at NIH in the Laboratory of Clinical Immunology and Microbiology in the National Institute of Allergy and Infectious Diseases.
Affiliations and expertise
Chief Scientific Officer, Clinical Center, Associate Director for Clinical Research, National Institutes of Health, Bethesda, MDAF
Anthony S. Fauci
Affiliations and expertise
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland U.S.A.Read Emerging Infections on ScienceDirect